Stay updated on AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the site version. This change does not modify study details, eligibility, locations, or participant information.
    Difference
    0.1%
    Check dated 2026-09-01T17:46:37.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.6.4 to v3.6.5 on the study page, signaling a new version of the page. This appears to be routine maintenance rather than a change to study details or core information.
    Difference
    0.1%
    Check dated 2026-08-11T22:08:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3. This appears to be a minor maintenance update without changes to study data or page content.
    Difference
    0.1%
    Check dated 2026-07-21T13:41:35.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.3, indicating a minor update or patch to the page.
    Difference
    0.1%
    Check dated 2026-06-30T02:12:14.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Recruitment status shows the study is no longer enrolling participants. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment header formatting was updated with a revision notice (Revision: v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-15T19:44:44.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, representing a small page rendering/update to the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-06-08T17:13:27.000Z thumbnail image

Stay in the know with updates to AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVANOVA: Niraparib vs Niraparib-bevacizumab in Ovarian Cancer Clinical Trial page.